Elsevier

The Journal of Pediatrics

Volume 115, Issue 3, September 1989, Pages 474-477
The Journal of Pediatrics

Drug screening of meconium in infants of drug-dependent mothers: An alternative to urine testing

https://doi.org/10.1016/S0022-3476(89)80860-1Get rights and content

Meconium specimens (first 3 days' stool) obtained from 20 infants of drug-dependent mothers and five control infants were analyzed by radioimmunoassay for the metabolites of three commonly abused drugs, heroin, cocaine, and cannabinoids. Control stools contained no drug. Meconium from the infants of drug-dependent mothers showed the presence of at least one drug metabolite: 80% of the infants of drug-dependent mothers showed cocaine (range 0.14 to 19.91 μg/gm stool), 55% showed morphine (range 0.41 to 14.97 μg/gm stool), and 60% showed cannabinoid (range 0.05 to 0.67 μg/gm stool). The concentrations of metabolites were highest during the first 2 days; some stools tested positive up to the third day. In contrast, only 37% of the infants had positive results on a urine screen (fluorescent polarization immunoassay method). Paired urine and meconium specimens, both analyzed by radioimmunoassay, showed a higher concentration of drug metabolites in the latter; eight urine samples had no detectable drugs despite a corresponding positive stool test result. We conclude that meconium is useful for drug screening in the neonate.

References (9)

There are more references available in the full text version of this article.

Cited by (190)

  • Drug testing in support of the diagnosis of neonatal abstinence syndrome: The current situation

    2023, Clinical Biochemistry
    Citation Excerpt :

    The proposed mechanism is that the fetus, once exposed to drug via passive diffusion across the placenta [47], excretes drug into bile and amniotic fluid. Drug accumulates in meconium either by direct deposition from bile or through swallowing of amniotic fluid [14,39,48]. The first evidence of meconium in the foetal intestine appears at approximately the 10th week to 12th week of gestation, and slowly moves into the colon by the 16th week of gestation [38] The presence of drugs in meconium has been proposed to be indicative of in utero drug exposure occurring from the end of the second trimester through the third trimester [39,49,50].

  • HPLC-DAD method for the quantitative determination of short-chain fatty acids in meconium samples

    2020, Microchemical Journal
    Citation Excerpt :

    It begins to form in fetus gastrointestinal tract between 12 and 16 weeks of pregnancy and accumulates until birth [24]. Meconium, unlike later feces has usually very dark green color and it is almost odorless [25]. It has a complex matrix composed of amniotic fluid residue, cellular debris like flaked cells of the skin and of digestive tract, gastrointestinal secretions and enzymes, lanugo, fatty material from the vernix caseosa, cholesterol and precursors of sterols, bile acids and salts, mucopolysaccharide blood group substances [26], proteins [27], sugars [28] as well as trace elements [29].

  • Biomonitoring pesticide exposure in nonconventional specimens

    2020, Exposure and Risk Assessment of Pesticide Use in Agriculture: Approaches, Tools and Advances
View all citing articles on Scopus
View full text